The Appraisal Panel considers the HTW appraisal evidence within the context of NHS Wales, and produces the HTW guidance. The panel also helps us to identify important topics, evaluates the uptake of guidance and facilitates stakeholder engagement. Current members are listed below.

Peter Groves

Dr Peter Groves

Consultant Interventional Cardiologist, Appraisal Panel Chair

Biography >
X Peter is a Consultant Interventional Cardiologist at the University Hospital of Wales. He is also Chair of the MHRA Devices Expert Advisory Committee and the NICE Medical Technologies Advisory Committee, and has a great interest in the regulation and health technology assessment of innovative medical devices in the context of the UK NHS. Peter is committed to teaching and research, and has published widely on the scientific basis for medical technology development and utilisation.
Saeed Ashraf

Professor Saeed Ashraf

Consultant, Cardiothoracic Surgeon

X

Judith Bowen

Nursing Director

X
HTW Placeholder

Dr Paul Buss

Medical Director, Paediatrician

Biography >
X Paul has been a Consultant Paediatrician since 1993 and has been involved in clinical management roles since 2003. He has been Chair of the All Wales Medicines Strategy Group, Chair of a ‘task and finish’ group for Non-Surgical Cosmetic Procedures in Wales, and Chair of the All Wales Medical Devices and Consumables Strategy Group. Paul’s chief interest is aligning clinical policy with evidence-based decision making and increasing senior clinical involvement in NHS resource decisions.
HTW Placeholder

Dr Tom Crosby

Consultant Oncologist

Biography >
X Tom is Medical Director of the Wales Cancer Network, Clinical Lead of Clinical Systems Transformation at Velindre Cancer Centre. He is based in Velindre Cancer Centre and currently specialises in upper gastrointestinal cancer; Tom is a leader in Upper Gastrointestinal Oesophageal Chemo-radiotherapy Research, Service and Development in the UK. Tom is also currently the clinical lead for the Transformation of Cancer Services Programme in South East Wales.

Andrew Davies

Director, Association of British HealthTech Industries

Biography >
X Andrew has worked in the medical technology sector for over 20 years. In his current role as Market Access Director at the Association of British HealthTech Industries, his responsibility is to ensure that reimbursement, evaluation and adoption mechanisms are aligned and optimised to support access for medical technologies. This entails creating an on-going dialogue between industry and policy makers to ensure efficient and effective diffusion structures, processes and methodologies are created and maintained.
Vinay Ellgar

Dr Vinay Eligar

Consultant, Diabetologist

X
HTW Placeholder

Ifan Evans

Director of Technology & Transformation, Welsh Government

Biography >
X Ifan is the Welsh Government lead for technology and innovation in health and care. He works closely with NHS Wales, universities and businesses to support open innovation partnerships, and the use of new and emerging technologies. Ifan also leads the delivery of A Healthier Wales, the new national plan for health and social care in Wales.

Prof. Chris Fegan

Consultant, Haemotologist

Biography >
X Chris is Director of Research & Development in Cardiff, and has a long-standing clinical and research interest in Chronic Lymphocytic Leukaemia (CLL). He is a member of the British Society of Haematology Guidelines group and the Clinical Trials Committees of the National Institute for Health Research CLL group. Chris has also been an expert medical advisor to NICE, and medical advisor to the charities Chronic Blood Cancer Support Group and Leukaemia Care.
HTW Placeholder

Julie Keegan

Director, Planning and performance

X
HTW Placeholder

Dr Sally Lewis

General Practitioner, Value based health care

Biography >
X Sally has front-line experience of primary care at its most challenging, as she rebuilt a struggling valley-based GP practice into one of the most successful in South East Wales. Her current interests include the utilisation of value-based principles to allocate resource in publicly funded systems, patient outcome data and digital transformation. Still practising as a GP, Sally is now National Clinical Director for Value-based and Prudent Healthcare, and Honorary Professor at Swansea School of Medicine.
HTW Placeholder

Dr Stephen Monaghan

Public Health Wales

Biography >
X Previously the Public Health Director of both Cardiff & Vale and ABM University Health Boards, Stephen is now a Consultant in Public Health Medicine for Public Health Wales. He is a member of the British Medical Association Welsh Council, and was previously Welsh Member on the UK’s Faculty of Public Health Board. Stephen is dual accredited by the General Medical Council as both a public health physician and general practitioner (GP).
Susan Myles

Dr Susan Myles

HTW Director

Biography >
X Susan has been engaged in applied health technology assessment for 25 years. Before joining Health Technology Wales, she led the development and work of the Scottish Health Technologies Group. Susan has received scholarships from the Department of Health and Medical Research Council, and is a previous recipient of a Harkness Fellowship in Health Care Policy. She holds qualifications in Economics (BA), Health Economics (MSc & PhD) and Epidemiology (PgDip).
HTW Placeholder

Clive Morgan

Assistant Director of Therapies

Biography >
X Clive is a Health and Care Professions Council (HCPC) registered Healthcare Scientist and Senior Healthcare Service leader with over 34 years of NHS experience. He is Medical Equipment, Decontamination, Statutory Regulation & Precision Medicine lead for Cardiff & Vale UHB, and gives advice to the Executive Team on all aspects of Health Care Science. Clive has a diverse portfolio of local and national governance, workforce, technology and innovation roles aligned to NHS Wales’ strategic objectives.
HTW Placeholder

Dr Wyn Parry

Medical Director, Powys Teaching Health Board

X
Ceri Phillips

Professor Ceri Phillips

Head of Human & Health Science, Swansea University, Academia representative

Biography >
X Ceri is Head of the College of Human and Health Sciences at Swansea University, and Professor of Health Economics at Swansea Centre for Health Economics. He is the University’s non-officer member of ABMU Health Board, and the current Chair of Council of Deans of Health Wales. Ceri was previously a member of the All Wales Medicines Strategy Group and a member of NICE Programme Development Groups on a range of public health issues.
Mark Roscrow

Mark Roscrow

Director, NHS Wales Shared Services Partnership

Biography >
X Mark has over 40 years’ experience in NHS finance. In 2011, he was appointed as the Director of the Procurement Division of the NHS Wales Shared Services Partnership, covering Sourcing, Supply Chain, Accounts Payable, Purchasing and Capital. In recognition of his efforts in public procurement, Mark was honoured for a lifetime of outstanding achievement at the National Government Opportunities Excellence in Public Procurement Awards, and was awarded a MBE in 2017.
Karen Samuels

Karen Samuels

Head of Patient Access to Medicines Service, All Wales Therapeutics & Toxicology Centre

Biography >
X Following a successful career in community and hospital pharmacy, Karen joined the All Wales Therapeutics and Toxicology Centre in 2003 as part of the Health Technology Assessment (HTA) team. In her current role as Head of HTA, Medicines Optimisation and Programme Director, Karen’s core role and key interest is making sure that patients have timely access to new clinically- and cost-effective medicines in Wales.

Dr Jared Torkington

Consultant, Colorectal surgeon

Biography >
X Jared is a Consultant Surgeon in Cardiff & Vale University Health Board. His clinical and research interests include Bowel Cancer and Laparoscopic Surgery. He was appointed Associate Medical Director for Innovation to support the new collaboration with Cardiff University in the field of Clinical Innovation. He chairs the novel Multidisciplinary Team approach to Clinical Innovation.
Gwyn Tudor

Gwyn Tudor

CEO, MediWales

Biography >
X For nearly 13 years, Gwyn has been Forum Manager for MediWales. Now as CEO, Gwyn works with the directors and members of MediWales to develop the forum’s future strategic direction. His in-depth knowledge of the life science sector allows him to represent MediWales’ members’ interests on a number of Welsh and UK government panels and boards.
Mark Walker

Dr Mark Walker

Deputy Medical Director, Betsi Cadwaladr UHB

Biography >
X Mark’s clinical background is mainly general practice. Working in Ysbyty Glan Clwyd, his interest lies in dermatology. He is Chair of the Betsi Cadwaladr UHB Individual Patient Funding Request Panel, the Drug and Therapeutics Group, and a member of the All Wales Medicines Strategy Group. He has facilitated or led commissioning and practical service development for many years, including working with Social Services to develop co-location and facilitate joint working within Primary Care.

Dr Lesa Wright

Consultant, Psychiatry & E-health

X

The Appraisal Panel includes senior representatives from every health board in Wales, alongside other key stakeholders. To learn more about the purpose of the group, see the HTW Appraisal Panel Terms of Reference.